Patient Guide: A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 22 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06701526
Status: 🟢 Enrolling Now
Condition: Migraine
Phase: PHASE4

Where You Can Participate

This study is available at 22 locations across the country.

Top locations include:
  • • Fresno, California
  • • Oakland, California
  • • San Marcos, California
  • • And 19 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications - Join Clinical Trial NCTNCT06701526

How to Join This Clinical Trial - NCTNCT06701526

Learn how to participate in this PHASE4 trial studying an investigational therapy for Migraine. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Migraine. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Migraine
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06701526 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 22 locations. Find a study site near you:

Clinical Research Site

Fresno, California 93710 - United States

Status: RECRUITING

Clinical Research Site

Oakland, California 94596 - United States

Status: RECRUITING

Clinical Research Site

San Marcos, California 92069 - United States

Status: RECRUITING

Clinical Research Site

Longmont, Colorado 80501 - United States

Status: RECRUITING

Clinical Research Site

Parker, Colorado 80138 - United States

Status: RECRUITING

Clinical Research Site

Stamford, Connecticut 06905 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33176 - United States

Status: RECRUITING

Clinical Research Site

West Palm Beach, Florida 33407 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30328 - United States

Status: RECRUITING

Clinical Research Site

Meridian, Idaho 83642 - United States

Status: RECRUITING

And 12 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Migraine:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships